Abiopharma

New Form 6-K - GSK plc Filed: 2025-06-24 AccNo: 0001654954-25-007326 Size: 16 KB

New Form 144 - Legend Biotech Corp Filed: 2025-06-24 AccNo: 0001959173-25-004260 Size: 5 KB

Investis Notification - Smith+Nephew PLC

New Form SCHEDULE 13G - Processa Pharmaceuticals, Inc. Filed: 2025-06-24 AccNo: 0001649553-25-000111 Size: 15 KB

Genprex Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Session

New Form 8-K - Genprex, Inc. Filed: 2025-06-24 AccNo: 0001437749-25-021093 Size: 171 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Candel Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145405 Size: 338 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 424B5 - Candel Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145401 Size: 515 KB

CNS Pharmaceuticals - New Press Release

Synaptongenix Notification (SNPX)

New Form 8-K - MAIA Biotechnology, Inc. Filed: 2025-06-24 AccNo: 0001641172-25-016235 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health

Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock

SeaStar Medical - SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy